Which of the following is an adverse reaction to topical nasal steroid?

Choice A rationale

Evidence of human fetal risk would categorize the drug as Category D or X, not Category B.

Choice B rationale

This statement aligns more with Category C drugs, where animal studies show adverse effects, but not Category B.

Choice C rationale

This describes Category A drugs, not Category B.

Choice D rationale

Category B drugs have shown no risk in animal studies but lack adequate human studies, fitting this description.

Choice A rationale

Barrier contraceptives are recommended for women taking HMG-CoA reductase inhibitors due to the potential teratogenic effects of these drugs. This precaution is crucial as these medications can cause fetal harm if used during pregnancy.

Choice B rationale

While ophthalmic examinations may be important for other medications, they are not a primary concern for HMG-CoA reductase inhibitors. These drugs mainly affect cholesterol synthesis and have less direct impact on vision.

Choice C rationale

Although a cholesterol-lowering diet is beneficial, it is not the primary teaching point when discussing HMG-CoA reductase inhibitors. The emphasis should be on medication adherence and managing potential adverse effects.

Choice D rationale

Reporting respiratory symptoms is important for many medications but is not the primary focus for HMG-CoA reductase inhibitors. The priority is to inform patients about the importance of contraception and potential side effects related to the medication.